# EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
> **NDA210649** · New Drug Application · Sponsor: MACLEODS PHARMS LTD · Approved 2019-03-15
## Drug
- **FDA Application Number:** NDA210649
- **Application type:** New Drug Application
- **Brand name:** EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
- **Generic name:** Efavirenz
- **Active ingredients:** EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MACLEODS PHARMS LTD
- **First approval:** 2019-03-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210649)
---
*AI Analytics · CC0 1.0*